These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 22209199)
1. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments. Krol S; Ellis-Behnke R; Marchetti P Maturitas; 2012 Sep; 73(1):61-7. PubMed ID: 22209199 [TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments. Krol S; Ellis-Behnke R; Marchetti P Nanomedicine; 2012 Sep; 8 Suppl 1():S69-76. PubMed ID: 22640905 [TBL] [Abstract][Full Text] [Related]
3. New ways of insulin delivery. Heinemann L Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicine and its potential in diabetes research and practice. Pickup JC; Zhi ZL; Khan F; Saxl T; Birch DJ Diabetes Metab Res Rev; 2008; 24(8):604-10. PubMed ID: 18802934 [TBL] [Abstract][Full Text] [Related]
5. New ways of insulin delivery. Heinemann L Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662 [TBL] [Abstract][Full Text] [Related]
6. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems. Card JW; Magnuson BA Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G956-67. PubMed ID: 21921287 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticle strategies for the oral delivery of insulin. Damgé C; Reis CP; Maincent P Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928 [TBL] [Abstract][Full Text] [Related]
11. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery. Klonoff DC Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014 [TBL] [Abstract][Full Text] [Related]
12. New developments in the treatment of type 1 diabetes mellitus. Haak T Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S108-13. PubMed ID: 10522818 [TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. [Biotechnological and administration innovations in insulin therapy]. Verge D Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494 [TBL] [Abstract][Full Text] [Related]
15. Recent approaches in insulin delivery. Trehan A; Ali A Drug Dev Ind Pharm; 1998 Jul; 24(7):589-97. PubMed ID: 9876502 [TBL] [Abstract][Full Text] [Related]
16. The Unitarian Hypothesis for the aetiology of diabetes mellitus. Morrison EY; Ragoobirsingh D; Peter SA Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731 [TBL] [Abstract][Full Text] [Related]
17. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung. Patton JS Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136 [TBL] [Abstract][Full Text] [Related]
18. Oral delivery of therapeutic protein/peptide for diabetes--future perspectives. Rekha MR; Sharma CP Int J Pharm; 2013 Jan; 440(1):48-62. PubMed ID: 22503954 [TBL] [Abstract][Full Text] [Related]
19. New strategies to improve the intranasal absorption of insulin. Duan X; Mao S Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545 [TBL] [Abstract][Full Text] [Related]
20. Inhaled insulin--does it become reality? Siekmeier R; Scheuch G J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]